15. REFERENCES

- Aldred, M.A., 1999. Gene therapy for eye cancer. Molecular Medicine Today 5 : 193.

- Anderson, W.F., Blease, R.M. and Culver K. 1990. The ADA human gene therapy clinical protocol; points to consider response with clinical protocols. Human Gene Therapy 1 (3 ) : 331-362.

- Anderson, W.F. 1992, Human gene therapy. Science 256 : 808-813.

- Aoki M. et al (1997). Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the b-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area.  Gene Ther., 4 : 120-127.

- Barinaga, P. (1994)“ Altering Human Genes: Social, Ethical, and Legal Implications” Perspective in Biology and Medicine 37 : 566-575.

- Brother, M. 1996 Block of tat – mediated transactivation of tumour necrosis factor beta gene expression by polymeric – TAR decoys. Virology 222 : 252-256.

- Caplen, N.J. 1998. TP 53 on trial for cancer gene therapy. Molecular Medicine Today 4 : 465.

- Caplen, N.J. 1998. Gene therapy: different strategies for different applications.  Molecular Medicine Today 4 : 373-374.

- Coi,D.W., Mukhopadhyar, T. and Roth J.A. 1995. Suppression of lung cancer cell growth by ribozyme-mediated modifications of P53 pre-mRNA.  Cancer  Gene therapy 2 : 199-205.

- Chang, C.C. 1998. Cord blood stem cell transplantation. Clinician Reviews 8 (2): 67-70 proliferative disorders with a constitutively active form of the retinoblastoma gene product.  Science, 267 : 518-522.

- Clayman G.L. et al 1998. Adenovirus – mediated p 53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin, Onco. 16, 2221-2232.

- Cristiano RJ, Curiel DT: Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Therapy 3 : 49-57, 1996.   

- Culver, K. V., and Blaese, R.M. 1994, Gene therapy for cancer. Trends  Genet, 10 : 174-178.

- Dachs, G.U. Dougherty, G.J. Stratford et al. 1997. Progress in gene therapy for cancer. Oncology Research g (6-7) 313-325.

- Dai Y, Schwarz, E.M., Gu, D., Zhang, W.W., Sarvetnick N., Verma, I.M. 1995, Cellular and humoral immune responses to adenoviral vectors containing factor IX gene : tolerization of factor IX and vector antigens allows for long – term expression Proc. Natl. Acad. Sci. USA 92 : 1401-1405.

- Davern, T.J. and Scharschmidt , B.F.1998. Gene therapy for liver disease.  Digestive Diseases, 16 : 1 23-37.

- Drake, M.L., Mang Yu, 1997. Gene therapy for HIV / AIDS Readers : 7 (6) : 184-190.

- Drumm ML, Pope HA, Cliff WH, et al 1990: Correction of the cystic fibrosis defect in vitro by retrovirus – mediated gene transfer Cell 62 : 1227-1233.

- Dunaief, J.L. Kwan, R.C. Bhardway, N. Lopez, R., Gouras, P. and Goff, S.P. 1995. Retroviral gene transfer into retinal pigment epithelial cells followed by transplantation into retina. Human gene therapy 6 : 1225- 1229.

- During, J.M. and Ashenden L.A. 1998. Towards gene therapy for the central nervous system.  Molecular Medicine Today 4 : 485-493.

- Edger H. and Tursz T..(1995) “ Report on Human Gene Therapy” Proceeding of International Bioethics committee of  UNESCO, 1 : 29-48.

- Edger H. and Tursz T. (1996)“ Ethical considerations regarding access to experimental treatment and expermentation on human  subject.”Proceeding of International Bioethics Committee of UNESCO  1 : 41-53.

- Ficazzola, M.A. and Taneja, S.S. 1998. Prospects for gene therapy in human prostate cancer, Molecular Medicine Today 4 : (11) : 494-504.

- Gloriosa, J.C., Deluca, N.A. and Fink, D.J., 1995. Development and application of herpes simplex virus vectors for human gene therapy. Annual Review of Microbiology; 49 : 675-710.

- Glorioso, J.C. Bender, M.A., Goins, W.F., Fink, D.J., and Deluca, N. 1995. HSV as a gene transfer vector for the nervous system. Molecular Biotechnology 4 : 87-99.

- Gilboa, E, Smith. C. 1994 Gene therapy for infectious diseases : The AIDS model.  Trends Genet 10 : 139-144.

- Goldman MJ, Yang Y, Wilson JM: 1995 Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect.  Nature Genetics 9 : 126-131.

- Goldman M, Su Q, Wilson JM: 1996 Gradient of RGD - dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis.  Gene Therapy 3 : 811- 818.

- Gordon, J.W. 1998. Germline alteration by gene therapy: assessing and reducing the risks.  Molecular medicine today, 4 : 468-470.

- Harris, J.D., and Lemoine, N.R. 1996. Strategies for targeted gene therapy.  Trends Genet 12 : 400- 405.

- Hayashi H. et al 1999. An experimental application of gene therapy for human retinoblastema. Invest. Opthal mol.

- HoA, Lix, 1995. Stem cells as vehicles for gene therapy : Novel strategy for HIV infection.  Stem cells 13 : 100-105.

- Ho, D., Neuman, A.U. Perelson, A.S. et al 1995. Rapid turnover of plasma virions and CD 4 lymphocytes in HIV infection. Nature 371 : 123-126.

- Ivanov, V. 1993 “Ethics and Human Genetics”, in council of Europe, “Second Symposium on Bioethics”, Stasbourg, 30/11-2/12.

- Jaffee, EM., Pardoll DM 1997. Considerations for the clinical Development of Cytokine. Gene – Transduced Tumor Cell Vaccines. Methods 12 (2) : 143-53.

- Johnson LG, Olsen JC, Sarkadi B, et al 1992: Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis.  Nature Genetics 2 : 21-25.

- Johnson LG, Boyles SE, Wilson J, et al 1995: Normalization of raised sodium absorption and raised calcium – mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cell.  J Clin Invest 95 : 1377-1382.

- Jones , D.R. and Bui, T.H.1998. Fetal therapy : prospects for transplantation early in pregnancy.  Molecular Medicine Today 4 : 10-11.

- Kaplitt, M.G., Darachiev, B. and  During, M.J. 1998, Prospects for gene therapy in pediatric neurosurgery Pediatric Neruosurgery, 28 (1) : 3-14.

- Karpati, G., Gilbert, R., Petrof, B.J., Nalbantoglu, 1997. Gene therapy research for Duchenne and Becker muscular dystrophies. Current opinion in Neurology, 10 : 430-435.

- Kasahara N, Dozy AM and Kahn YW 1994 tissue specific targeting of retroviral vectors through ligand-receptor interactions. Science 255 : 1373-1376.

- Kaplitt, M.G., Darakchiev, B. and During M.J, 1998. Prospects for gene therapy in pediatric neurosurgery. Pediatric Neurosurgery, 28 : (1) : 3-14.

- Kay, M.A., and Woo, S.L.C. 1994. Gene therapy for metabolic disorders.  Trends Genet. 10 : 253-257.

- Kerr W.G. 1998. Genetic modification of the hematolymphoid compartment for therapeutic prposes.

- Klug, W. and Cummings, M.R. 1997. Concepts of genetics 5th ed. Pub. Prentice Hall.

- Kotin, R.M. 1994. Prospects for the use of adeno – associated virus as a vector for human gene therapy.  Human gene therapy ; 5 : 793-801.

- La Face, D.M. and Mang Yu 1997. Gene therapy for HIV/AIDS : Where are we going . The AIDS Reader 7 (6) : 184-190.

- Lamarch, P., Ari, J.H. and Danel, C. et al 1992. Adenovirus mediated transfer of a recombinant human 1-antitrypsin cDNA to human endothelial cells, Proc Notl. Acad. Sci. USA 89 : 6482-6486.

- Lasic, D.D. 1998. Novel applications of liposomes. Trends in Biotechnol. 16 : 307-321.

- Ledley, F.D. 1995. Non-viral gene therapy: The promise of genes as pharmaceutical products.  Human Gene Therapy 6 : 1129-1144.

- Levine, F. and Leibowitz, G. 1999. Towards gene therapy of diabetes mellitus.  Molecular Medicine Today 5 : 165-171.

- Licht, T, Herrmann F, Gottesman, M.M. et al 1997. In vivo drug-selectable genes.  A new concept in gene therapy.  Stem cells 15 (2) : 104-111.

- Liu, J. Woffendin, C. Yang, Z. et al : 1994. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.  Human Gene Therapy 1 : 32-37.

- Marcel T., Grausz JD: The TMC, 1997 worldwide gene therapy enrollment report, end 1996.  Human Gene Therapy 8 : 775-800.

- Mendell, J.R. Kissel, J.T., Amato, A.A. et al 1995. Myoblast transfer in the treatment of Duchenn’s muscular dystrophy N. Engl. J. Med, 333 : 832-838.

- Mettal S.K., McDermott M.R., Johnson D.C. et al 1993. Monitoring foreign gene expression by human adenovirus based vector using the fire luciferase gene as a reporter. Virus Res. 28 : 67-90.

- Morgan, R.A. and Anderson, W.F. 1993. Human gene therapy. Annu Rev. Biochem-62 : 191-217.

- Mulligan, R.C. 1993. The basic science of gene therapy. Science 260 : 926-932.

- Morgan, R.A. and Anderson, W.F. 1993. Human gene therapy. Annu. Rev. Biochem, 62 : 191-217.

- Mulligan, R.C. 1993. The basic science of gene therapy. Science 260 :   96-932.

- Muzycka N: (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Microbiol and Immunol 158 : 97-128, 1992.

- Nikol,S. and Fling, B.H. 1998, Gene therapy for restenosis: Progress or frustration. J. Invas Cardiol 10 (8) :  506-514.

- Ohno, T. Gordon, D. San, H. et al 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science, 265 : 781-784.

- Overturf K. et al. 1998. Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia type I.  Hum. Gene Ther., 9 :  295-304.

- Perales, J.C., Ferkol, T. Molas, M. and Hanson R.W. 1994. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. European Journal of Biochemistry 226 : 255-266.

- Poeschla, E. 1995-1996. Gene therapy and HIV disease. AIDS clinical reviews : 1-45.

- Paulus, W. Baur, I. Boyce, F.M. Breakefield, and Reeves, S.A. 1996.  Self-contained, tetracycline- regulated retroviral vector system for gene delivery to mammalian cells.  Journal of Virology 70 : 62-67.

- Prazeres, D.M.F., Ferreira, G.N.M., Monteiro G.A. et al 1999. Large scale production of pharmaceutical- grade plasmid DNA for gene therapy: problems and bottlenecks.  Trends Biotechnol. 17 ( 4 ) : 169-174.

- Reynolds, P.N., Feng, M. and T. David. 1994. Chimeric viral vectors the best of both worlds.  Molecular Medicine Today 5 : 25-31.

- Rich DP, Anderson MP, Gregory RJ, et al 1990: Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347 : 358-363.

- Riordan JR, Rommens JM, Kerem B et al1989: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.  Science 245 (4922) : 1066-73.

- Robbins, P.D., Tahara, H. and Ghivizzani S. 1998. Viral vectors for gene therapy.  Trends in Biotechnol. 16: 35 -40.

- Rock, K. L., Gramm, C., Rothstein, L. et al 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules.  Cell 78 :  761-771.

- Rommens JM, Lannuzzi MC, Kerem B, et al 1989: Identification of cystic fibrosis gene: chromosome walking and jumping. Science 245 (4922) : 1059-1065.

- Rosenfeld, M.A., Siegfried, Yoshimura K et al 1990. Adenovirus mediated transfer of a recombinant a-antitrypsin gene to the lung epithelium in vivo.  Science, 252 : 431-434.

- Roth, J.A., Cristiano, R.J. 1997. Gene therapy for cancer: What have we done and where are going?  Journal of National canc.  Inst. 89 (1) : 21- 39.

- Roth, J.A. et al 1998. Gene therapy for non-small cell lung cancer: a preliminary report of a phase 1 trial of adenoviral p. 53 gene replacement.  Semin. Onco. 25, 33-37.

- Salmons, B. and Gunzburg WH. 1993. Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4 : 129-141.

- Schiedner G. et al 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet., 18 : 180-183.

- Senior, K. 1998. In utero gene therapy: one step close to reality. Molecular Medicine Today 4 : 505.

- Senut, M.C. and Gage, F.H. 1999. Prenatal gene therapy: can the technical hurdles be overcome? Molecular Medicine Today 5 : 152-156.

- Simons, K. H. Garoff, and A. Helenius, 1982. How an animal virus gets into and out of its host cell.  Sci. Am. Feb : 58.

- Snowden, M.M. and Grove, R.I. 1998. Gene therapy for cardiovascular diseases.  Expert Opinion on Therapeutic Patents, 8 : 509-520.

- Stratford – Perricaudet L.D., Makeh I, Perri caudet M. et al 1992. Widespread long term gene transfer to mouse skeletal muscles and heart J. Clin. Invest. 90 : 626-630.

- Tanswell, A.K. and O Brodovich, 1997. The present and future role of gene therapy in new born.

- Tsukui T. et al 1996. Transgenesis by adenovirus – mediated gene transfer into mouse zone – free eggs.  Nat. Biotechnol., 14 : 982-985.

- Varmus, H.E. 1982. Form and function of retroviral proviruses. Science 216 : 812.

- Varmus, H.E. 1988. Retrovirus Science 240 : 1427.

- Vile, R.G. 1996. Gene therapy for treating cancer: hope or hype? Chemistry and industry, 8 : 285-289.

- Ulmer, J.B., Dommelly, J.J., Parker, S.E. et al 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein.  Science, 259 : 781-784.

- United State President’s Commission for The Study of Ethical Problems in Medicine and Biomedical Behavioral Research “ Splicing Life” (1982).

- Wagner E., Zatloukal K, Cotton M, Kirlappos H, Mechtler K, Curied D T and Birnstiel ML. 1992. Coupling of adenovirus to transferrin-polylysine /DNA complexes greatly enhances receptor – mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89 : 6099-6103.

- Wagner, J.A. and Gardner, P. 1997. Toward cystic fibrosis gene therapy.  Annu. Rev. Med. 48 :  203-216.

- Walters L. (1991) “Human Gene Therapy : Ethics and Public Policy” Human Gene Therapy 2 : 115-122

- Welch, P. Hampel A. , Barber J. et al 1996.  Inhibition of HIV replication by the hairpin ribozyme. In Eckstein, F., Lilley (eds) : Nucleic acids and molecular biology vol 10 Berlin Heidlberg, Springer – Verlag, pp 315-327.

- Wei, X, Ghosh, S.K., Taylor, M.E. et al, 1995. Viral dynamics in human immunodeficiency virus type –1 infection. Nature 371 : 117- 122.

- Welsh , M. J. and Ostedgoard, L.S. 1998.  Cystic fibrosis problem probed by proteolysis.  Nature Structural Biology 5 : 167-169.

- Wich MS. 1998. The prospects for development of gene therapy for treatment and prevention of breast cancer 21st Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

- Wilson, J. M. 1996. Adenoviruses as gene – delivery vehicles. N Engl. J. Med. 334 : 1185-1187.

- Wilson JM 1995: Gene therapy for cystic fobrosis: challenges and future directions.  J Clin Invest 96 : 2547-2554.

- Woffendin, C., Yang, Z. Y, Udaydumar, Xul et al : 1994. Nonviral and viral delivery of human immunodeficiency virus protective gene in primary human Tcells.  Proc. Natl Acad. Sci. USA 91 : 11581-11585.

- Wolf, J. H. 1994. Recent progress in gene therapy for inherited diseases.  Current opinions in Pediatrics; 6 : 213-218.

- Wu, J. Wu, G.Y. and Zern, M.A. 1998. The prospects of hepatic drug delivery and gene therapy. Expert Opinion on Investigational Drugs, 7: 1795-1817.

- Yang Y, Ertl, H.C., Wilson J.M. 1994, MHC class 1-restricted cytotoxic T lymphocytes to viral antigens destroy hypatocytes in mice infected with E1 – deleted recombinant adenoviruses.  Immunity; 1 : 433 -442.

- Yang, Y., Nunes, F.A., Berencsi, K., Gonczol, E., Engelhardt, J. F., Wilson, J.M. 1994.  Inactivation of E2a in recombinant adenoviruses improves the prospect of gene therapy in cystic fibrosis.  Nat Genet, 7 :  362-369.

- Yu, M, Ojwang, J. Yamada, O. et al 1993. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1.  Proc. Natl. Acad. Sci. USA 90 : 6340-6344.